Stanoject – SP Laboratories

Pharmaceutical form: Injectable suspension

Concentration: 50 mg/ml

Active substance (per 1 ml):Stanozolol – 50 mg

Description:

Stanoject is an injectable preparation containing stanozolol, a synthetic anabolic steroid derived from dihydrotestosterone (DHT). It exhibits strong anabolic effects with relatively low androgenic activity. Unlike testosterone-derived esters, stanozolol does not aromatize, so it does not convert to estrogen and typically does not cause water retention.

Indications (medical use):

Originally developed for therapeutic applications such as anemia and muscle-wasting conditions.

Administration:

Intramuscular injection, according to medical prescription.

Possible adverse reactions:

Hepatotoxicity, adverse changes in lipid profile, potential joint or tendon discomfort, suppression of endogenous testosterone production.

Packaging:

10 ml multidose vial (concentration 50 mg/ml)